Evidence map›Paper›PMID 42529495›Full record

ArticleCase reports in hematology2026

Hyperviscosity Syndrome, Hypercalcemia, and Acute Renal Failure as Initial Manifestations of Multiple Myeloma in an Octogenarian.

Wen-Chun Yu, Hui-Yun Chiu, Hung-Bin Tsai

Abstract read
In one paragraph

Article in Case reports in hematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wen-Chun YuDepartment of Nursing, National Taiwan University Hospital, Taipei, Taiwan, ntuh.gov.tw.ORCID https://orcid.org/0009-0002-7445-6724
Hui-Yun ChiuDepartment of Nursing, National Taiwan University Hospital, Taipei, Taiwan, ntuh.gov.tw.
Hung-Bin TsaiDivision of Hospital Medicine, Department of Internal Medicine, Taipei City Hospital Zhongxing Branch, Taipei, Taiwan, taipei.gov.tw.ORCID https://orcid.org/0000-0002-0689-8339

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple myeloma (MM) is a hematological malignancy characterized by the proliferation of abnormal plasma cells, often accompanied by the excessive secretion of monoclonal immunoglobulins. Hyperviscosity syndrome (HVS) is a rare but life-threatening complication that leads to microcirculatory impairment and organ dysfunction. Additionally, hypercalcemia, commonly associated with osteolytic bone destruction, can further result in acute kidney injury and altered consciousness. Case Presentation: We describe an 80-year-old male who presented with confusion, generalized weakness, decreased urine output, and fever. He was subsequently diagnosed with MM complicated by HVS, hypercalcemia, and acute renal failure. Initial investigations revealed severe anemia, significantly elevated IgG levels (8612.26 mg/dL), multiple osteolytic lesions, and deteriorating renal function. The patient also exhibited epistaxis and neurological symptoms. Emergency plasmapheresis was initiated, alongside calcitonin and supportive therapy for hypercalcemia. Bone marrow examination confirmed plasma cell myeloma. Following five sessions of plasmapheresis, immunoglobulin levels decreased significantly, and clinical symptoms improved markedly. The patient was then successfully transitioned to immunomodulatory agents and systemic chemotherapy. Conclusion: MM presenting with HVS and hypercalcemia can be rapidly fatal. Early recognition and immediate intervention with plasmapheresis and supportive care are crucial for improving patient outcomes and facilitating subsequent oncological treatment.

Indexed as

hypercalcemiahyperviscosity syndromemultiple myeloma

Identifiers

PMID42529495
PMCPMC13418199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.